Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Johnson & Johnson
(NY:
JNJ
)
154.64
+0.36 (+0.23%)
Official Closing Price
Updated: 7:00 PM EDT, May 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Johnson & Johnson
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
94
95
Next >
Check Out What Whales Are Doing With JNJ
October 19, 2023
Via
Benzinga
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
October 19, 2023
Investors wonder if the healthcare giant can keep raising its payout now that it no longer sells the consumer health brands that made it famous.
Via
The Motley Fool
7 Dividend Aristocrats That Are Built to Last
October 19, 2023
For dependability and durability, take a closer look at these seven dividend stocks, all of which hold aristocratic status.
Via
InvestorPlace
Why Johnson & Johnson Stock Flopped Today
October 18, 2023
Perhaps those third-quarter results weren't as impressive as they first appeared to be.
Via
The Motley Fool
Positive Outlook On Johnson & Johnson's Partner Legend Biotech: Analyst Confident On Blood Cancer Drug
October 18, 2023
Legend Biotech Corporation's (NASDAQ: LEGN) partner, Johnson & Johnson (NYSE: JNJ), reported Q3 Carvykti revenues of $152 million,
Via
Benzinga
1 Warren Buffett Stock to Buy Hand Over Fist Right Now
October 18, 2023
This blue-chip healthcare stock is a solid pick for investors in uncertain times.
Via
The Motley Fool
Johnson & Johnson Earnings Preview
October 16, 2023
Via
Benzinga
Johnson & Johnson Resumed The Bearish Cycle
October 16, 2023
Johnson & Johnson (JNJ) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods.
Via
Talk Markets
Dividend Income Update September 2023
October 18, 2023
With the start of the final quarter of 2023, it’s time to take a look back at my previous month of dividend income.
Via
Talk Markets
Is the "New" Johnson & Johnson Stock a Buy With Its Improved Profit Outlook?
October 18, 2023
Some things are different about J&J. But other things remain the same as they've been for a long time.
Via
The Motley Fool
Johnson & Johnson's Sharper Focus Is Already Paying Dividends for Investors
October 17, 2023
The healthcare behemoth reported strong earnings after separating its consumer health division.
Via
The Motley Fool
Back for Another Round: Rate Hike Fears Grow After Strong Retail Sales Sends Yields Spinning Higher
October 17, 2023
(Tuesday market open) Early earnings results continued to impress but major indexes flagged in premarket trading Tuesday as Treasury yields swung higher after unexpectedly strong September U.S. Retail...
Via
Benzinga
Johnson & Johnson's Q3 2023: $21.3B Rise In Sales, 'Sharpened Focus' On Innovation & Biotech Solutions
October 17, 2023
Healthcare company Johnson & Johnson (J&J) (NYSE: JNJ) shared its financial outcomes for the third quarter of 2023, reflecting:
Via
Benzinga
Johnson & Johnson (JNJ) Q3 2023 Earnings Call Transcript
October 17, 2023
JNJ earnings call for the period ending September 30, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Johnson & Johnson Was Saved By Its Focus On MedTech And Innovative Medicine
October 17, 2023
Johnson & Johnson (NYSE: JNJ) reported its third quarter results that topped Wall Street’s expectations while also lifting its full year guidance fueled by a strong performance of its pharmaceutical...
Via
Benzinga
Iran Warning Stops The Market Rally Buy Historic Biden Visit To Israel Is A Positive For The Market
October 17, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Johnson & Johnson Is Falling, but This Tech Stock Is Really Getting Hit Hard
October 17, 2023
Earnings season is starting to ramp up.
Via
The Motley Fool
Johnson & Johnson Raises Outlook As The Health Care Bellwether Beats Views
October 17, 2023
The company beat third-quarter forecasts and raised its outlook for the year. It's now focusing on innovative drugs and medtech following its consumer health spinoff.
Via
Investor's Business Daily
New Johnson & Johnson's Q3 Earnings Beat Street View, Raises Annual Outlook
October 17, 2023
Johnson & Johnson (NYSE: JNJ) has reported Q3 FY23 adjusted earnings of $2.66 per share, up 19.3% Y/Y and beating the conse
Via
Benzinga
Topics
Earnings
Exposures
Financial
US Stock Futures Slide As Traders Look Past Positive Earnings News Flow; Analysts Predict Year-End Rally And Strong 2024 Ahead
October 17, 2023
Via
Benzinga
Earnings Scheduled For October 17, 2023
October 17, 2023
Companies Reporting Before The Bell • Goldman Sachs Gr (NYSE:GS) is projected to report quarterly earnings at $5.31 per share on revenue of $11.14 billion.
Via
Benzinga
Bank of America, Johnson & Johnson And 3 Stocks To Watch Heading Into Tuesday
October 17, 2023
With U.S. stock futures trading lower this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:
Via
Benzinga
Pendulum Swings: Markets Recover Slightly After Friday's Anxious Trading, But Middle East Worries Dominate
October 16, 2023
(Monday market open) Last week gave us a taste of earnings. The meal starts tomorrow and picks up steam as banks, airlines, and health care companies report.
Via
Benzinga
Monday's Market Minute: This Week's Focus: Earnings & Consumer Spending
October 16, 2023
The focus for investors and traders will shift from inflation after the higher-than-expected figures last week to earnings and consumer spending habits.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
4 Dividend Stocks Yielding 4% or More to Buy Without Hesitation
October 16, 2023
These stocks offer attractive payouts that should rise in the future.
Via
The Motley Fool
US Stocks On Track For A Strong Start To Week, Buoyed By Earnings Optimism: Analyst Flags 13-14% Upside As Bull Market Enters Its Second Year
October 16, 2023
US stocks appear on track to start higher on Monday as traders look ahead to the earnings season to serve as upside catalyst.
Via
Benzinga
Tesla, Netflix Grab Earnings Spotlight This Week As Analysts Divided On Q3 Reporting Season: What's On Investors' Radar?
October 16, 2023
While analysts look forward to the unfolding reporting season with guarded optimism, they are skeptical regarding forward guidance.
Via
Benzinga
Johnson & Johnson Stock: Is Now the Time to Sell?
October 14, 2023
Conservative investors buy Johnson & Johnson for the dividend, but that payout is less safe after its Kenvue spinoff
Via
InvestorPlace
3 Dividend Growth Stocks You Can Buy and Hold Forever
October 14, 2023
Investors can sit back and let the dividends flow in with these great stocks.
Via
The Motley Fool
Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets
October 13, 2023
Higher-than-expected inflation data this week caught markets off guard, and the Israel-Hamas conflict is sending the markets running to safer assets.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
...
15
16
17
18
19
20
21
22
23
...
94
95
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.